According to the American Diabetes Association, more than 34 million Americans have diabetes. That’s equal to 10% of the population in the USA. To date the most common treatment has been to manage the disease with diet and insulin shots, when requred.
Further research is required, however this new research could lead to a cure in humans.
Researchers at the Washington University, St. Louis, Missouri were able to cure diabetes in mice by infusing them with stem cells.
Diabetes affects the ability of the body of producing and managing insulin, which is normally produced by the pancreas. When this happens, body insulin levels need to be monitored regularly and expensive insulin shots need to be administered if blood sugar levels shoot up. According to the researchers, the findings provide a much reliable alternative— using beta cells to generate insulin for diabetics.
The treatment works using pluripotent stem cells. These cells can actually shape-shift into becoming any kind of cells in the body. However, the process is not perfect. The cells can also morph into other types of cells. The cells are harmless but do affect the ratio of the insulin-producing cells, affecting the efficacy of the treatment.
The G20 group of the world’s wealthiest nations have agreed for the first time to collectively sound the alarm over the threat to the financial system posed by the climate emergency.
Overcoming objections from Donald Trump’s US administration, G20 finance ministers and central bank governors meeting in Saudi Arabia over the weekend agreed to issue their first ever communique with references to climate change, according to reports from Reuters.
Researchers at T.H. Chan School of Public Health at Harvard University, who will have their findings published Wednesday in the New England Journal of Medicine, also suggest that more than half of the population in 29 U.S. states will be obese.
Currently, the analysis estimates that 40 percent of American adults are obese, with 18 percent severely so.
“Prevention is going to be key to better managing this epidemic” of obesity,” lead author Zachary Ward, programmer/analyst at Harvard’s Center for Health Decision Science, said in a press release.
Heart disease and cancer still kill most Americans, but they weren’t the reason people are dying younger. In fact, deaths from heart disease have been declining. Between 2006 and 2016, however, death rates from from drug overdoses increased 72 percent and for suicides, 23 percent.
So who lives longest? According to the report, Hispanics had the highest life expectancy at 81.8 years. Non-Hispanic whites were next, with 78.5 years, followed by non-Hispanic blacks, with 74.8 years.
Stilwell, Oklahoma, known as the Straberry Capital of the worlk earned a discouraging distinction: It has the lowest life expectancy in the USA — just 56.3 years. That is 22.5 years less than the comparable national average of 78.8 years.
“People who live blocks apart can have very different expectations in how long they’ll live because of the conditions in which people are living,” said Donald Schwarz, a senior vice president at the Robert Wood Johnson Foundation. “That represents uneven opportunity for people, particularly children, to have long lives.”
A Consumer Reports investigation states the United States Department of Agriculture’s (USDA) own research shows that drugs prohibited by the U.S. Food and Drug Administration (FDA) are being detected in U.S. produced beef, poultry, and pork. And the USDA, which is responsible for food safety in the USA, is not doing anything about it.
Not only are there 2.3 million new diagnoses, the number of new cases is accelerating year over year.
New cases of chlamydia, gonorrhoea and syphilis rose sharply for the fourth consecutive year in 2017, to a record high of nearly 2.3 million, according to new data from the Centers for Disease Control and Prevention.
That number surpassed the previous record, which was set in 2016, by more than 200,000 cases.
The Food and Drug Administration on Thursday approved the first generic version of EpiPen, providing new competition that could help drive down the cost of a lifesaving product that had become a notorious symbol of high drug prices.
The generic copy is made by Teva Pharmaceuticals USA, and will rival Mylan, which had come under intense criticism for raising the price of its EpiPen sixfold since buying it in 2007. Mylan’s device has been plagued by periodic shortages, with consumers scrambling again in recent months to find a reliable supply.
Every day I dive into the internet cesspool and go through a pile of news sources to extract the most fascinating stories. Curated by hand. No large media organizations. No bots. No unambiguous algorithms deciding what you get to read.
This site is for informational purposes only, and is not a substitute for good judgement, common sense, medical advice, or treatment provided by a qualified health care provider.